Advisornet Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12
| Closed | -$199 | – | 2203 |
|
|
2025
Q1 | $199 | Hold |
12
| – | – | ﹤0.01% | 2052 |
|
|
2024
Q4 | $220 | Hold |
12
| – | – | ﹤0.01% | 1856 |
|
|
2024
Q3 | $185 | Buy |
+12
| New | +$185 | ﹤0.01% | 2114 |
|
|
2024
Q1 | – | Sell |
-740
| Closed | -$23.2K | – | 2021 |
|
|
2023
Q4 | $23.2K | Hold |
740
| – | – | ﹤0.01% | 1037 |
|
|
2023
Q3 | $15.4K | Hold |
740
| – | – | ﹤0.01% | 1118 |
|
|
2023
Q2 | $17.7K | Hold |
740
| – | – | ﹤0.01% | 1135 |
|
|
2023
Q1 | $13.9K | Hold |
740
| – | – | ﹤0.01% | 1201 |
|
|
2022
Q4 | $11.8K | Hold |
740
| – | – | ﹤0.01% | 1247 |
|
|
2022
Q3 | $12K | Hold |
740
| – | – | ﹤0.01% | 1259 |
|
|
2022
Q2 | $10K | Hold |
740
| – | – | ﹤0.01% | 1317 |
|
|
2022
Q1 | $18K | Hold |
740
| – | – | ﹤0.01% | 1263 |
|
|
2021
Q4 | $17K | Hold |
740
| – | – | ﹤0.01% | 1314 |
|
|
2021
Q3 | $12K | Hold |
740
| – | – | ﹤0.01% | 1385 |
|
|
2021
Q2 | $18K | Hold |
740
| – | – | ﹤0.01% | 1240 |
|
|
2021
Q1 | $19K | Sell |
740
-110
| -13% | -$2.82K | ﹤0.01% | 1189 |
|
|
2020
Q4 | $45K | Buy |
850
+110
| +15% | +$5.82K | ﹤0.01% | 890 |
|
|
2020
Q3 | $31K | Hold |
740
| – | – | ﹤0.01% | 959 |
|
|
2020
Q2 | $36K | Hold |
740
| – | – | ﹤0.01% | 934 |
|
|
2020
Q1 | $31K | Hold |
740
| – | – | ﹤0.01% | 936 |
|
|
2019
Q4 | $32K | Sell |
740
-24
| -3% | -$1.04K | ﹤0.01% | 1027 |
|
|
2019
Q3 | $27K | Buy |
+764
| New | +$27K | ﹤0.01% | 1094 |
|